A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients
1 other identifier
interventional
6
0 countries
N/A
Brief Summary
Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Oct 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedStudy Start
First participant enrolled
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
October 2, 2025
October 1, 2025
1.2 years
September 10, 2025
October 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Respiratory sleep monitoring
The average length of sleep in a week Sleep breathing monitoring was determined by evaluation before and after treatment. The main purpose of this study was to observe whether the average sleep time of patients increased significantly after treatment.
From enrollment to the end of treatment for 3 weeks
Secondary Outcomes (1)
Pittsburgh sleep quality index,PSQI
From enrollment to the end of treatment for 3 weeks
Study Arms (2)
transcranial magnetic stimulation
NO INTERVENTIONAromatherapy + transcranial magnetic stimulation
EXPERIMENTALExperimental:Aromatherapy + transcranial magnetic stimulation 1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.2.The r repetitive transcranial magnetic acupuncture apparatus produced by Jiangxi brain Control Technology Development Co., Ltd. is used and operated by professional therapists.Before treatment, the resting exercise threshold of each patient was tested: 10 pulse stimuli were given to find out the lowest stimulus intensity that could cause more than 50 microvolts.Parameter setting: 90% RMT 1Hz, each sequence lasts 12s, stimulation 10s, interval 2s. The treatment time was 20min/, once per day for 5 days per week, lasting for 3 weeks.
Interventions
1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of stroke
- Insomnia patients
- Sign the informed consent form, cooperate voluntarily
- Accord with the diagnosis of "insomnia" in traditional Chinese medicine
- Evaluation has no taboo on transcranial magnetism
- The age range is between 24 and 65
You may not qualify if:
- Disturbance of consciousness
- Cognitive impairment
- Mental abnormality
- Sleep apnea syndrome
- Restless leg syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dandan Wulead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 10, 2025
First Posted
October 2, 2025
Study Start
October 8, 2025
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
October 2, 2025
Record last verified: 2025-10